NRx Pharmaceuticals Inc.
NRXP | NASDAQ
$3.29
-$0.03 (-0.90%)
At close: Sep 21, 2026, 4:00 PM ET
$3.29
$0 (0.00%)
Pre-market:
Sep 22, 2026, 9:24 AM ET
Market Data
Market Cap $56.87M
Enterprise Value $31.02M
Beta 2.19
Average Volume 1.14M
Shares Outstanding (Diluted) 37.65M
Shares Change YoY 109.93%
Institutional Ownership 19.20%
Exchange NASDAQ
ISIN US6294442099
Price Performance
Price Change 1M -7.6%
Price Change 3M -12.5%
Price Change 6M 36.5%
Price Change YTD 25.6%
Price Change 1Y 14.6%
Price Change 3Y 28.5%
Price Change 5Y -96.5%
1M CAGR (ann.) -8.1%
1Y CAGR (ann.) 10.4%
5Y CAGR (ann.) -50.4%
All-Time CAGR -31.8%
Valuation
PE Ratio -4.45
Forward PE 8.94
PEG Ratio -0.04
Forward PEG 0.09
PS Ratio 16.76
Forward PS 0.60
PB Ratio -334.53
P/FCF Ratio -2.75
P/Adj. FCF Ratio -2.69
P/OCF Ratio -6.21
EV/Sales 9.14
EV/EBIT -2.47
EV/EBITDA -2.57
EV/FCF -1.50
Earnings Yield -22.5%
FCF Yield -36.4%
Adj. FCF Yield -37.1%
Financial Health
Net Cash $25.85M
Total Debt $834K
Cash & Short-Term Investments $26.69M
Total Assets $34.16M
Current Ratio 0.86
Quick Ratio 0.86
Debt / Equity Ratio -7.33
Debt / EBITDA -0.07
Debt / FCF -0.04
OCF / Debt -23.71
Interest Coverage -17.45
Altman Z-Score -13.60
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 32.7%
Operating Profit Margin -588.2%
EBITDA Margin -647.1%
Net Profit Margin -691.8%
FCF Margin -609.0%
Adj. FCF Margin -622.0%
SBC / Revenue 12.9%
SBC Impact (per share) -2.1%
Returns
Return on Assets -68.7%
Return on Equity 168.7%
Return on Invested Capital -1855.5%
Return on Capital Employed -6980.8%
Return on Tangible Assets -74.5%
Historical Growth (CAGR)
Revenue CAGR 3Y 150.0%
Revenue CAGR 5Y 100.0%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 43.2%
EPS CAGR 5Y 16.8%
EPS CAGR 10Y N/A
FCF CAGR 3Y -18.4%
FCF CAGR 5Y 29.4%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 5
EPS Growth Next 3Y 65.3%
Revenue Growth Next 3Y 512.0%
Earnings Date Nov 12, 2026
EPS Estimate (next Q) -$0.26
EPS Growth Est (next Q) -3.7%
Revenue Est (next Q) $1.33M
Revenue Growth Est (next Q) 448.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $2
Price Target Upside -39.2%
Cash Flow
Operating Cash Flow $-19.77M
Free Cash Flow $-20.67M
Adj. Free Cash Flow $-21.11M
FCF Per Share -$0.55
OCF Per Share -$0.53
OCF/S Ratio -582.6%
Income Statement
Revenue $3.39M
Gross Profit $1.11M
Operating Income $-19.97M
EBITDA $-12.08M
Net Income $-23.48M
EPS (Diluted) -$0.74
Revenue / Employee $117.03K
Profit / Employee $-809.66K
Employees 29
Add to Watchlist
Select watchlists to add or remove NRXP